[SCHEDULE 13G (Amendment No. 1)* (Name of Issuer) (Title of Class of Securities) (CUSIP Number) (Date of Event Which Requires Filing of This Statement) o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities,]
[W ashington FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES SINOVAC BIOTECH LTD. Antigua, West Indies Not Applicable (State or other jurisdiction (I.R.S. Employer Identification of incorporation or organization) Number) No. 39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Not Applicable (Zip Code) Title of each class to be so registered ___________________________________ Name of each]
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent Rights Agreement Dated as of March 28, 2016 RIGHTS AGREEMENT Agreement Company Rights Agent Rights Agreement, dated as of March 28, 2016 (this “ RECITALS Board Right Section 1.6 Record Date Sections 3.1 and 7.1 Series A Preferred Shares provided, however, Section 22 WHEREAS, the Board of Directors (the] [Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights The Rights Plan is designed to assure that all of the Company’s shareholders receive fair and equal treatment in the event of any proposed takeover of the Company and to guard against partial tender offers, open market accumulations and other abusive or coercive tactics to gain] []
[SINOVAC BIOTECH LTD. and PACIFIC STOCK TRANSFER COMPANY as Rights Agent Rights Agreement Dated as of March 28, 2016 RIGHTS AGREEMENT Agreement Company Rights Agent Rights Agreement, dated as of March 28, 2016 (this “ RECITALS Board Right Section 1.6 Record Date Sections 3.1 and 7.1 Series A Preferred Shares provided, however, Section 22 WHEREAS, the Board of Directors (the] [Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights The Rights Plan is designed to assure that all of the Company’s shareholders receive fair and equal treatment in the event of any proposed takeover of the Company and to guard against partial tender offers, open market accumulations and other abusive or coercive tactics to gain] []
[SCHEDULE 13G/A (Amendment No. 1)* Sinovac Biotech Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this]
[SCHEDULE 13G/A (Amendment No. 1)* Sinovac Biotech Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this]
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
[January 30, 2016 The Board of Directors Sinovac Biotech Ltd. No. 39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Members of the Board of Directors Company Buyer Group Proposal Transaction 2 We believe that our Proposal provides a very attractive opportunity to the Company’s shareholders. Our Proposal represents a premium of approximately 23.11% to the] []
[January 30, 2016 The Board of Directors Sinovac Biotech Ltd. No. 39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Members of the Board of Directors Company Buyer Group Proposal Transaction 2 We believe that our Proposal provides a very attractive opportunity to the Company’s shareholders. Our Proposal represents a premium of approximately 23.11% to the] []
